Annual report
2385.TEDINET S100P8YZ
Period2021-07-01 → 2022-06-30
Filed2022-09-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥8.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.6bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2017-07-01 → 2018-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥917m | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥920m | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥878m | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥341m | 2017-07-01 → 2018-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥908m | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥810m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥732m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥553m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥198m | 2017-07-01 → 2018-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥817m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥581m | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥8.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥7.1bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥7.4bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.3bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.6bn | at 2018-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.6bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥915m | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥5.8bn | at 2020-06-30d | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥4.6bn | at 2018-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.3bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.0bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.0bn | at 2018-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥107m | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥830m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥469m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥74m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥245m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥25m | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥693m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥289m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥130m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥131m | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥103m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥52m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥276m | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥30.95 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.49 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.97 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.16 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.57 | 2017-07-01 → 2018-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥254.14 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥230.88 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥214.39 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥190.87 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥171.84 | at 2018-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 78.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.7% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.5% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.6% | at 2018-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.8% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.7% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.8% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2017-07-01 → 2018-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 100 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 104 | at 2021-06-30 | Cons. | Number of employees |
| Employees | 105 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 101 | at 2019-06-30d | Cons. | Number of employees |
| Employees | 97 | at 2018-06-30d | Cons. | Number of employees |
| Revenue | ¥439m | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥425m | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥425m | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥303m | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥289m | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥134m | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥130m | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | ¥137m | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥132m | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥116m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥73m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12m | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥137m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥132m | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | ¥195m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥288m | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | ¥155m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥111m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥60m | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.5bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥4.2bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥4.1bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥196m | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥22m | at 2021-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.3bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.1bn | at 2020-06-30d | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥953m | at 2021-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥7.47 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.02 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.91 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.26 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.29 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥163.52 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥161.05 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥155.03 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥153.56 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.43 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 95.6% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.5% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.6% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.3% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.0% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.6% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.5% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 26,158,200 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,158,200 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 9 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 8 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 8 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 7 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 5 | at 2018-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 93
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥237,000 |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥9m |
| Reconciling Itemsreconciling | revenue external | 2021-07-01 → 2022-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥11m |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥304m |
| Clinical Evidence Servicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5m |
| Clinical Evidence Servicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2m |
| Clinical Evidence Servicereportable segment | employees | at 2022-06-30 | 23 pure |
| Clinical Evidence Servicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥552m |
| Clinical Evidence Servicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥552m |
| Clinical Evidence Servicereportable segment | segment assets | at 2022-06-30 | ¥453m |
| Clinical Evidence Servicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥6m |
| Functional Cosmetic Retailingreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5m |
| Functional Cosmetic Retailingreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥11m |
| Functional Cosmetic Retailingreportable segment | employees | at 2022-06-30 | 28 pure |
| Functional Cosmetic Retailingreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥5.0bn |
| Functional Cosmetic Retailingreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥5.0bn |
| Functional Cosmetic Retailingreportable segment | segment assets | at 2022-06-30 | ¥3.7bn |
| Functional Cosmetic Retailingreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥1.1bn |
| Functional Food Retailingreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥34m |
| Functional Food Retailingreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥3m |
| Functional Food Retailingreportable segment | employees | at 2022-06-30 | 23 pure |
| Functional Food Retailingreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | segment assets | at 2022-06-30 | ¥1.3bn |
| Functional Food Retailingreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥200m |
| Functional Material Developmentreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2m |
| Functional Material Developmentreportable segment | employees | at 2022-06-30 | 10 pure |
| Functional Material Developmentreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥569m |
| Functional Material Developmentreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥558m |
| Functional Material Developmentreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥11m |
| Functional Material Developmentreportable segment | segment assets | at 2022-06-30 | ¥1.3bn |
| Functional Material Developmentreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥83m |
| Health Care Support Servicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥709,000 |
| Health Care Support Servicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥1m |
| Health Care Support Servicereportable segment | employees | at 2022-06-30 | 7 pure |
| Health Care Support Servicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥549m |
| Health Care Support Servicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥549m |
| Health Care Support Servicereportable segment | segment assets | at 2022-06-30 | ¥330m |
| Health Care Support Servicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥117m |
| —segment total | capex | 2021-07-01 → 2022-06-30 | ¥45m |
| —segment total | depreciation | 2021-07-01 → 2022-06-30 | ¥20m |
| —segment total | revenue | 2021-07-01 → 2022-06-30 | ¥9.4bn |
| —segment total | revenue external | 2021-07-01 → 2022-06-30 | ¥9.3bn |
| —segment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥11m |
| —segment total | segment assets | at 2022-06-30 | ¥7.2bn |
| —segment total | segment profit | 2021-07-01 → 2022-06-30 | ¥1.5bn |
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥245,000 |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥508,000 |
| Reconciling Itemsreconciling | revenue | 2020-07-01 → 2021-06-30 | −¥25m |
| Reconciling Itemsreconciling | revenue external | 2020-07-01 → 2021-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-07-01 → 2021-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | ¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥293m |
| Clinical Evidence Servicereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥14m |
| Clinical Evidence Servicereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥6m |
| Clinical Evidence Servicereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥553m |
| Clinical Evidence Servicereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥536m |
| Clinical Evidence Servicereportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥17m |
| Clinical Evidence Servicereportable segment | segment assets | at 2021-06-30 | ¥454m |
| Clinical Evidence Servicereportable segment | segment profit | 2020-07-01 → 2021-06-30 | −¥31m |
| Functional Cosmetic Retailingreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥8m |
| Functional Cosmetic Retailingreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥13m |
| Functional Cosmetic Retailingreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥4.4bn |
| Functional Cosmetic Retailingreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥4.4bn |
| Functional Cosmetic Retailingreportable segment | segment assets | at 2021-06-30 | ¥2.6bn |
| Functional Cosmetic Retailingreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥777m |
| Functional Food Retailingreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥284,000 |
| Functional Food Retailingreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥3m |
| Functional Food Retailingreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥2.7bn |
| Functional Food Retailingreportable segment | segment assets | at 2021-06-30 | ¥1.3bn |
| Functional Food Retailingreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥221m |
| Functional Material Developmentreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥3m |
| Functional Material Developmentreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥807m |
| Functional Material Developmentreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥798m |
| Functional Material Developmentreportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥9m |
| Functional Material Developmentreportable segment | segment assets | at 2021-06-30 | ¥1.4bn |
| Functional Material Developmentreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥171m |
| Health Care Support Servicereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥339,000 |
| Health Care Support Servicereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥1m |
| Health Care Support Servicereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥451m |
| Health Care Support Servicereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥451m |
| Health Care Support Servicereportable segment | segment assets | at 2021-06-30 | ¥249m |
| Health Care Support Servicereportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥72m |
| —segment total | capex | 2020-07-01 → 2021-06-30 | ¥23m |
| —segment total | depreciation | 2020-07-01 → 2021-06-30 | ¥27m |
| —segment total | revenue | 2020-07-01 → 2021-06-30 | ¥9.0bn |
| —segment total | revenue external | 2020-07-01 → 2021-06-30 | ¥8.9bn |
| —segment total | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥26m |
| —segment total | segment assets | at 2021-06-30 | ¥5.9bn |
| —segment total | segment profit | 2020-07-01 → 2021-06-30 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,274
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents | CurrentYearInstant | 6017253000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 5 | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method | CurrentYearInstant | － | |
| Accounts receivable trade | CurrentYearInstant | 699953000 | JPY |
| Contract assets | CurrentYearInstant | 75561000 | JPY |
| Write downs of inventories | Prior1YearDuration | 39384000 | JPY |
| Write downs of inventories | CurrentYearDuration | 92816000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 468938000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 484875000 | JPY |
| Depreciation sga | Prior1YearDuration | 20327000 | JPY |
| Depreciation sga | CurrentYearDuration | 16822000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 80176000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 37011000 | JPY |
| Advertising expenses sga | Prior1YearDuration | 717947000 | JPY |
| Advertising expenses sga | CurrentYearDuration | 755250000 | JPY |
| Promotion expenses sga | Prior1YearDuration | 442352000 | JPY |
| Promotion expenses sga | CurrentYearDuration | 322948000 | JPY |
| Packing and transportation expenses sga | Prior1YearDuration | 402496000 | JPY |
| Packing and transportation expenses sga | CurrentYearDuration | 388447000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | -5333000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | -1409000 | JPY |
| Provision for point card certificates sga | Prior1YearDuration | 14086000 | JPY |
| Provision for point card certificates sga | CurrentYearDuration | － | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | 535933000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05367-000HealthCareSupportServiceReportableSegmentsMember | 451469000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | 4411542000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalFoodRetailingReportableSegmentsMember | 2744421000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 797630000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 8940996000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | 1500000 | JPY |
| Revenues from external customers | Prior1YearDuration | 8942496000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | 17111000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05367-000HealthCareSupportServiceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalFoodRetailingReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 9070000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | 26181000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -26181000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | 553044000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E05367-000HealthCareSupportServiceReportableSegmentsMember | 451469000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | 4411542000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalFoodRetailingReportableSegmentsMember | 2744421000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalMaterialDevelopmentReportableSegmentsMember | 806700000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 8967178000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | -24681000 | JPY |
| Net sales | Prior1YearDuration | 8942496000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E05367-000ClinicalEvidenceServiceReportableSegmentsMember | -31280000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E05367-000HealthCareSupportServiceReportableSegmentsMember | 71551000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E05367-000FunctionalCosmeticRetailingReportableSegmentsMember | 777008000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |